Malignant Mesothelioma in Body Fluids - with Special Reference to Differential Diagnosis from Metastatic Adenocarcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Paik, Jin Ho | - |
dc.contributor.author | Chung, Jin-Haeng | - |
dc.contributor.author | Kim, Baek-Hui | - |
dc.contributor.author | Choe, Gheeyoung | - |
dc.date.accessioned | 2021-09-08T12:45:04Z | - |
dc.date.available | 2021-09-08T12:45:04Z | - |
dc.date.created | 2021-06-11 | - |
dc.date.issued | 2009-10 | - |
dc.identifier.issn | 1738-1843 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/119142 | - |
dc.description.abstract | Background : Malignant mesothelioma (MM) is a rare malignant neoplasm occurring in pleura, pericardium, and peritoneum. The differential diagnosis between MM and metastatic adenocarcinoma (MA) causes diagnostic, staging, and therapeutic dilemmas. Herein, we investigated characteristic cytologic features of MM. Methods : Cytologic specimens of MM (n=10), MA (n=25) and reactive mesothelial hyperplasia (n=10) were retrieved and reviewed from archival materials in the Department of Pathology, Seoul National University Bundang Hospital from May 2003 to July 2008. Results : MM showed tumor cell clusters and singly scattered malignant tumor cells forming single cell populations with sparse reactive benign mesothelial cells. In contrast, MA showed distinct two cell populations of tumor cell clusters and scattered reactive mesothelial cells. Furthermore, MM frequently exhibited a characteristic long chain-like arrangement (hand-in-hand appearance) and intercellular windows, which were rarely evident in MA. Variable nuclear size, relatively consistent nuclear-cytoplasmic ratio, i or multi-nucleation, and lacy cytoplasmic borders were also frequently observed in MM. Conclusions : Differential diagnosis of MM from MA in body fluids is possible based on meticulous examination of certain cytologic parameters, which could have significant implications in staging and treatment. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOCIETY PATHOLOGISTS | - |
dc.subject | PLEURAL MESOTHELIOMA | - |
dc.subject | ANTIBODIES | - |
dc.subject | MARKER | - |
dc.subject | PANEL | - |
dc.title | Malignant Mesothelioma in Body Fluids - with Special Reference to Differential Diagnosis from Metastatic Adenocarcinoma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Baek-Hui | - |
dc.identifier.doi | 10.4132/KoreanJPathol.2009.43.5.458 | - |
dc.identifier.scopusid | 2-s2.0-77951156588 | - |
dc.identifier.wosid | 000271500000012 | - |
dc.identifier.bibliographicCitation | KOREAN JOURNAL OF PATHOLOGY, v.43, no.5, pp.458 - 466 | - |
dc.relation.isPartOf | KOREAN JOURNAL OF PATHOLOGY | - |
dc.citation.title | KOREAN JOURNAL OF PATHOLOGY | - |
dc.citation.volume | 43 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 458 | - |
dc.citation.endPage | 466 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001385784 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Pathology | - |
dc.relation.journalWebOfScienceCategory | Pathology | - |
dc.subject.keywordPlus | PLEURAL MESOTHELIOMA | - |
dc.subject.keywordPlus | ANTIBODIES | - |
dc.subject.keywordPlus | MARKER | - |
dc.subject.keywordPlus | PANEL | - |
dc.subject.keywordAuthor | Cytology | - |
dc.subject.keywordAuthor | Mesothelioma | - |
dc.subject.keywordAuthor | Adenocarcinoma | - |
dc.subject.keywordAuthor | Body fluids | - |
dc.subject.keywordAuthor | Diagnosis | - |
dc.subject.keywordAuthor | Differential | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.